Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Induced Pluripotent Stem Cells: Generation, Characterization, and Differentiation--Methods and Protocols.

Veronica Kon Graversen1, Sai H Chavala2

  • 1Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Methods in Molecular Biology (Clifton, N.J.)
|November 19, 2014
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and efficacy of MCO-010 optogenetic therapy in patients with Stargardt disease in USA (STARLIGHT): an open-label multi-center Ph2 trial.

EClinicalMedicine·2025
Same author

Neuroprotective and Anti-Inflammatory Activities of Hybrid Small-Molecule SA-10 in Ischemia/Reperfusion-Induced Retinal Neuronal Injury Models.

Cells·2024
Same author

The endothelin receptor antagonist macitentan ameliorates endothelin-mediated vasoconstriction and promotes the survival of retinal ganglion cells in rats.

Frontiers in ophthalmology·2024
Same author

Case Report: Endogenous Candida Endophthalmitis in Cornelia de Lange Syndrome: Atypical Stellate Neuroretinitis.

Optometry and vision science : official publication of the American Academy of Optometry·2021
Same author

Acute Orbital Compromise after Intra-Arterial Chemotherapy in a Complex Retinoblastoma Associated with 13q Deletion Syndrome.

Pediatric neurosurgery·2020
Same author

History through the eyes of a pandemic.

Current opinion in ophthalmology·2020

Induced pluripotent stem cells (iPSC) offer cell replacement therapy potential. Ocular ciliary body epithelial cells (CECs) show high reprogramming efficiency, making them promising for future strategies.

Area of Science:

  • Stem cell biology
  • Regenerative medicine
  • Cellular reprogramming

Background:

  • Induced pluripotent stem cells (iPSC) are crucial for cell replacement therapies.
  • Various somatic cell types have been investigated for their reprogramming capabilities.
  • Ocular ciliary body epithelial cells (CECs) are a novel cell source for reprogramming.

Purpose of the Study:

  • To evaluate the reprogramming potential of ocular ciliary body epithelial cells (CECs).
  • To assess the efficiency of reprogramming CECs into induced pluripotent stem cells (iPSCs).
  • To explore the feasibility of single transcription factor reprogramming in CECs.

Main Methods:

  • Fibroblast reprogramming protocols.
  • Isolation and culture of ocular ciliary body epithelial cells (CECs).
Keywords:
Ciliary body epithelial cellsInduced pluripotent stem cellsReprogrammingSomatic cellsTranscription factors

Related Experiment Videos

  • Assessment of reprogramming efficiency and pluripotency markers.

    • Main Results:

    • CECs demonstrated high reprogramming efficiency.
    • Successful generation of induced pluripotent stem cells (iPSCs) from CECs.
    • Feasibility of single transcription factor-mediated reprogramming was observed.

    Conclusions:

    • Ocular ciliary body epithelial cells (CECs) are a highly efficient source for generating induced pluripotent stem cells (iPSCs).
    • Single transcription factor reprogramming of CECs is achievable.
    • CECs represent a promising cell source for regenerative medicine and cell-based therapies.